Centre d'Estudis Epidemiològics sobre les ITS i Sida de Catalunya

You are here

2010 | CEEISCAT

Publicacions 2010

 

 

Barczyk J, García J, Casabona J. The potential contribution of small-scale intervention projects in the field to the national health information system for HIV and sexually transmitted infections: a case study of a multilevel intervention in Guatemala. Int J Public Health. 2010 Dec; 55(6):693-9. doi: 10.1007/s00038-010-0179-7.

 

Marshall V, Martró E, Labo N, Ray A, Wang D, Mbisa G, Bagni Rachel K, Volvfovsky N, Casabona J, Whitby D; EURO-SHAKS Study Group. Kaposi Sarcoma (KS)–associated Herpesvirus MicroRNA Sequence Analysis and KS Risk in a European AIDS-KS Case Control Study. J Infect Dis. 2010 Oct 1;202(7):1126-35. doi: 10.1086/656045.

 

Corbeto E,  Lugo R,  Martró E, Falguera G,  Ros R, Avecilla A, Coll  C,Saludes V,Casabona J. Epidemiological features and determinants for Chlamydia trachomatis infection among women in Catalonia, Spain. Int J STD AIDS. 2010 Oct;21(10):718-22. doi: 10.1258/ijsa.2010.010223.

 

The Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE). Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/mL? Clin Infect Dis. 2010 Sep 1;51(5):611-9. doi: 10.1086/655761.

 

Martin-Iguacel R, Llibre JM, Nielsen H, Heras E, Matas L, Lugo R, Clotet B, Sirera G. Lymphogranuloma Venereum Proctocolitis: a Silent Endemic Disease in Men who have Sex with Men in Industrialised Countries. Eur J Clin Microbiol Infect Dis. 2010 Aug;29(8):917-25. doi: 10.1007/s10096-010-0959-2.

 

Study Group on Death Rates at High CD4 Count in Antiretroviral Naive Patients. Death rates in HIV-positive antiretroviral-naive patients with with CD4 count greater than 350 cells per μL in Europe and North America: a pooled cohort observational study. Lancet. 2010 Jul 31;376(9738):340-5. doi: 10.1016/S0140- 6736(10)60932-4.

 

Fernàndez-Lopez L, Rifà B, Pujol F, Becerra J, Pérez M, Meroño M, Zaragoza K, Rafel A, Díaz O, Avellaneda A, Casado MJ, Giménez A, Casabona J. Impact of the introduction of rapid HIV testing in the Voluntary Counselling and Testing sites network of Catalonia, Spain. Int J STD AIDS. 2010 Jun;21(6):388-91. doi: 10.1258/ijsa.2008.008459.

 

The Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996 - 2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010 May 15;50(10):1387-96. doi: 10.1086/652283.

 

Huntington S, Folch C, González V, Meroño M, Ncube F, Casabona J. Prevalencia de VIH, Hepatitis C y factores asociados en usuarios de drogas por vía parenteral seleccionados en Cataluña. Enferm Infecc Microbiol Clin. 2010 Apr;28(4):236-8. doi: 10.1016/j.eimc.2009.06.004.

 

Buzón MJ, Massanella M, Llibre JM, Esteve A, Dahl V, Puertas MC, Gatell JM, Domingo P, Paredes R, Sharkey M, Palmer S, Stevenson M, Clotet B, Blanco J, Martinez-Picado J. HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects. Nat Med. 2010 Apr;16(4):460-5. doi: 10.1038/nm.2111.

 

Folch C, Esteve A, Zaragoza K, Muñoz R, Casabona J. Correlates of intensive alcohol and drug use in men who have sex with men in Catalonia, Spain. Eur J Public Health. 2010 abr.;20(2):139-45. doi: 10.1093/eurpub/ckp091.

 

The Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE). Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years. Arch Intern Med. 2010 Mar 8;170(5):410-9. doi: 10.1001/archinternmed.2009.472.

 

Folch C, Casabona J, Muñoz R, González V, Zaragoza K. Incremento en la prevalencia del VIH y en las conductas de riesgo asociadas en hombres que tienen sexo con hombres: 12 años de encuestas de vigilancia conductual en Cataluña. Gac Sanit. 2010 Jan-Feb;24(1):40-6. doi: 10.1016/j.gaceta.2009.06.010.

 

The HIV-CAUSAL Collaboration. The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS. 2010 Jan; 24(1):123-37. doi: 10.1097/QAD.0b013e3283324283.